Low dose Azanucleosides for high risk (s)MDS and AML. Hematology Meeting Reports, [S. l.], v. 2, n. 15, 2009. DOI: 10.4081/hmr.v2i15.613. Disponível em: https://journals.pagepress.net/hmr/article/view/613. Acesso em: 1 may. 2026.